Williams Sarah Joanne sold ANTX

September 1, 2026 · Form 4 insider transaction

Williams Sarah Joanne sold 272 shares of AN2 Therapeutics, Inc. at $5.53 per share, a transaction worth $1.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
272
Price
$5.53
Total value
$1.5K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 1, 2026
Filing dateSeptember 4, 2026
Shares owned after66,311
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on August 28, 2026.; Includes (a) 48,375 RSUs which vest as follows: 1/4th of the shares vests in substantially equal installments annually (rounded down to the nearest whole number of shares) over four years from January 1, 2026, and the balance of (b) 10,938 RSUs which vest as follows: 1/4th of the RSUs vests in substantially equal installments annually (rounded down to the nearest whole number of shares) over four years from January 1, 2025, and (c) 11,850 RSUs which vest as follows: 1/16th of the RSUs vests in substantially equal installments quarterly (rounded down to the nearest whole number of shares) over four years from May 28, 2024, in each case subject to the Reporting Person's continuous service through each applicable vesting date. A total of 4,038 shares from the aggregate number of the RSUs issued under (b) and (c) above were sold to cover taxes and a total of 814 shares were sold on the open market.

View the original Form 4 on SEC EDGAR
Williams Sarah Joanne sold ANTX: September 1, 2026 | Insider Trading Screener